기도 관리 디바이스 시장 : 제품 유형, 재료, 삽입 기술, 최종사용자, 용도, 사이즈별 - 세계 예측(2025-2032년)

The Airway Management Devices Market is projected to grow by USD 3.63 billion at a CAGR of 8.17% by 2032.

A comprehensive introduction to airway management device dynamics, clinical imperatives, technological evolution, and stakeholder decision drivers shaping device adoption

Airway management devices remain central to acute care delivery, perioperative safety, and prehospital stabilization, driven by the persistent need to secure and protect patient airways across diverse care settings. Clinicians and procurement leaders alike prioritize devices that deliver reliable placement, reduced complication risk, and ease of use under pressure. In parallel, healthcare systems increasingly emphasize device lifecycle costs, sterilization standards, and compatibility with existing clinical workflows, which together shape purchasing and adoption decisions.

Technological innovation has intensified the conversation around operator training, human factors, and interoperability. Advances in visualization, materials science, and single-use designs are redefining expectations for performance and contamination control. Meanwhile, demographic shifts-aging populations and rising rates of complex comorbidities-sustain demand for robust airway solutions across hospitals, emergency medical services, ambulatory surgical centers, and home care environments. Consequently, stakeholders must balance clinical efficacy with procurement pragmatism and regulatory compliance to navigate a rapidly evolving landscape.

How visualization advancements, infection control priorities, supply chain resilience, and digital integration are collectively transforming airway device procurement and clinical workflows

The landscape for airway management devices is undergoing several transformative shifts that are reshaping procurement priorities and clinical routines. First, the transition from traditional direct visualization techniques toward video-enabled systems has altered training paradigms and device selection criteria, as clinicians seek solutions that improve first-pass success and documentation capability. Second, infection prevention concerns and the broad adoption of single-use or easily reprocessed designs have elevated material selection and supply chain resilience to strategic importance.

Furthermore, integration with digital workflows and the rise of telemedicine-supported emergency care are prompting manufacturers to embed connectivity and data capture into device platforms. Regulatory expectations have likewise tightened, with more rigorous evidence requirements for device performance under varied clinical conditions. Concurrently, supplier consolidation and strategic partnerships between device innovators and large healthcare distributors are influencing availability and pricing dynamics. Together, these shifts demand that hospitals and EMS providers reassess training, maintenance, and procurement strategies to align with technology-enabled, patient-safety-focused care models.

Assessing how recent tariff measures have reshaped sourcing strategies, supplier footprints, and procurement priorities across the airway device value chain

The cumulative impact of tariff measures enacted through 2025 has introduced additional complexity for stakeholders that rely on global sourcing for components and finished airway devices. Tariff pressures have influenced supplier selection, prompting many purchasers to reassess total landed costs, inventory buffers, and contractual terms with international vendors. Manufacturers have responded by optimizing manufacturing footprints, diversifying supplier bases for critical components such as polymers and optics, and, in several instances, negotiating long-term supply agreements to mitigate exposure to tariff volatility.

In practice, these adjustments have translated into longer lead times for certain catalog items and an increased emphasis on supplier transparency about country-of-origin and cost pass-through mechanisms. Health systems and distributors have adapted by expanding strategic procurement planning horizons and by qualifying regional alternatives to maintain continuity of supply. Importantly, clinicians and procurement teams now weigh tariff-related logistics and supply security alongside clinical performance and sterile processing requirements when evaluating device options, which has elevated the role of supply chain intelligence within clinical purchasing decisions.

Clear segmentation-driven insights that link product type, material selection, insertion technique, end user setting, application context, and patient size to procurement and clinical priorities

Segmentation insights reveal where clinical needs, device design, and procurement priorities intersect most acutely, offering a practical lens for product strategy and supply planning. Product type distinctions such as Endobronchial Tubes, Endotracheal Tubes with their Cuffed and Uncuffed variants, Intubation Stylets, Laryngeal Mask Airways, and Laryngoscopes drive divergent requirements in materials, sterilization, and clinical training. Material choices between Polyvinyl Chloride and Silicone inform disposability, patient comfort, and sterilization pathways, with silicone increasingly preferred where flexibility and biocompatibility are paramount.

Insertion technique continues to be a defining segmentation axis, as Direct Laryngoscopy and Video Laryngoscopy present separate value propositions for first-pass success, training time, and capital equipment considerations. End user settings such as Ambulatory Surgical Centers, Emergency Medical Services, Home Care Settings, and Hospitals exhibit distinct procurement cycles, storage constraints, and clinical competency profiles that shape device configuration and service needs. Application segments including Emergency Care, Home Care, Intensive Care, Operating Room, and Pre Hospital emphasize different performance attributes, from rapid deployment to prolonged airway maintenance, while size categories spanning Adult, Neonatal, and Pediatric necessitate tailored design and certification pathways. Together, these segmentation dimensions underscore the necessity for manufacturers and suppliers to develop differentiated product lines, training packages, and logistical solutions that meet the nuanced demands of each clinical and operational context.

A regional perspective that connects clinical adoption patterns, regulatory nuances, and supply chain realities across the Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert powerful influence over clinical practice patterns, regulatory environments, and supply chain architecture, requiring stakeholders to adopt regionally nuanced strategies. The Americas continue to emphasize rapid adoption of video laryngoscopy in tertiary centers, coupled with decentralized procurement models that value group purchasing organization contracts and local distribution networks. In contrast, Europe, Middle East & Africa present a heterogeneous regulatory and reimbursement environment where adoption rates vary significantly by country, and where procurement decisions often balance cost-containment with national infection control guidelines.

Asia-Pacific features accelerated uptake of innovative airway technologies in urban centers alongside significant variability in clinical training and infrastructure in rural areas, which creates opportunities for both high-end visualization systems and robust, low-complexity devices for broader deployment. Across regions, supply chain resilience, regulatory alignment, and localized training programs determine how quickly new device classes transition from early adoption to standard practice. Consequently, global suppliers must blend centralized product development with localized commercialization and service strategies to address distinct regional needs effectively.

How manufacturer innovation priorities, production strategies, and strategic partnerships are redefining competitive positioning and value propositions across the sector

Key company dynamics reflect strategic choices around innovation, manufacturing footprint, regulatory strategy, and channel partnerships. Leading manufacturers are investing in visualization technology and user-centric device ergonomics while expanding production capacity for single-use formats to address infection control imperatives. Concurrently, several firms are pursuing modular platforms that support both direct and video visualization modalities, enabling cross-selling into hospital networks that seek standardized training and maintenance processes.

Strategic alliances between device innovators and distributors have accelerated market access in complex healthcare systems, and vertically integrated supply relationships have emerged to safeguard component availability. Moreover, some companies are differentiating through services such as clinician training programs, digital documentation tools, and extended warranty or maintenance offerings. These moves signal a broader shift toward solution-oriented business models where recurring service revenue and clinical outcomes data play an increasing role in procurement decisions.

Actionable strategic recommendations to align clinical adoption, procurement resilience, and training programs with technology-enabled device portfolios and supplier partnerships

Industry leaders should pursue a set of actionable steps to secure clinical relevance and supply reliability while accelerating adoption and lifecycle value. First, integrate procurement and clinical stakeholders early in product evaluation to align device capabilities with operational workflows, training capacity, and sterilization processes; this collaborative approach reduces integration risk and shortens time-to-clinical-value. Second, diversify component sourcing and qualify regional manufacturing options to minimize exposure to trade disruptions, thereby improving continuity of supply and enabling more predictable procurement cycles.

Third, invest in clinician-focused training and competency programs that accompany product deployment, emphasizing simulation-based practice for both direct and video laryngoscopy techniques to maximize first-pass success rates. Fourth, enhance device portfolios with modular offerings and compatible disposables tailored to specific end user settings, which enables targeted commercial strategies for ambulatory surgical centers, emergency responders, home care providers, and hospitals. Finally, build data collection and digital documentation capabilities into device ecosystems to demonstrate real-world performance and support post-market surveillance, thereby increasing trust with clinical buyers and payers.

A transparent research methodology combining primary clinical, procurement and supply chain inputs with regulatory and technical evidence to ensure actionable and validated insights

This research synthesized primary interviews with clinical experts, procurement leaders, and supply chain managers, coupled with a rigorous review of regulatory approvals, device design literature, and publicly available clinical guidelines. Data collection emphasized device performance metrics, sterilization protocols, and real-world operational constraints to capture the full scope of adoption drivers across care settings. Analytical steps included cross-segmentation mapping to identify high-priority product and end user intersections, supplier landscape analysis to assess manufacturing and distribution footprints, and scenario-based evaluation of supply chain vulnerabilities under varying tariff and logistical conditions.

Quality assurance encompassed methodological triangulation and verification of technical specifications against regulatory filings and published clinical evaluations. The approach prioritized transparency in data sources, clear documentation of inclusion criteria for devices and technologies evaluated, and iterative validation with domain experts to ensure practical relevance for clinical and procurement stakeholders.

A strategic conclusion emphasizing clinical performance, infection control, supply chain resilience, and regional customization as the pillars of future airway device success

In conclusion, airway management devices occupy a critical intersection of clinical efficacy, infection control, and supply chain resilience, requiring manufacturers and health systems to adopt integrated strategies that align design, training, and distribution. The ongoing shift toward video-enabled systems, single-use options, and materials that support sterilization and patient comfort is reshaping procurement criteria, while tariff-driven supply chain adjustments have elevated the importance of manufacturing diversification and supplier transparency. Regional differences in adoption, regulation, and infrastructure further underscore the need for tailored commercialization and service models.

As stakeholders navigate this evolving environment, the organizations that combine robust clinical validation, adaptable product portfolios, and resilient supply chain practices will be best positioned to meet the complex demands of modern airway management. The resulting opportunities lie in delivering devices and services that not only meet clinical performance expectations but also integrate seamlessly into the operational realities of diverse care settings.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Growth driven by integration of high-resolution imaging in video laryngoscopes enhancing visualization and success rates
• 5.2. Adoption of single-use disposable supraglottic airway devices to reduce infection risk and streamline workflow in operating rooms
• 5.3. Rising demand for smart airway management systems with real-time monitoring and data analytics capabilities
• 5.4. Increasing focus on ergonomic design improvements in endotracheal tubes to minimize patient trauma and ease intubation
• 5.5. Surge in development of wireless connected capnography modules for remote patient monitoring and digital health integration
• 5.6. Expansion of the pediatric airway management segment fueled by specialized low-profile devices and advanced training simulators

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Airway Management Devices Market, by Product Type

• 8.1. Endobronchial Tubes
• 8.2. Endotracheal Tubes
  • 8.2.1. Cuffed
  • 8.2.2. Uncuffed
• 8.3. Intubation Stylets
• 8.4. Laryngeal Mask Airways
• 8.5. Laryngoscopes

9. Airway Management Devices Market, by Material

• 9.1. Polyvinyl Chloride
• 9.2. Silicone

10. Airway Management Devices Market, by Insertion Technique

• 10.1. Direct Laryngoscopy
• 10.2. Video Laryngoscopy

11. Airway Management Devices Market, by End User

• 11.1. Ambulatory Surgical Centers
• 11.2. Emergency Medical Services
• 11.3. Home Care Settings
• 11.4. Hospitals

12. Airway Management Devices Market, by Application

• 12.1. Emergency Care
• 12.2. Home Care
• 12.3. Intensive Care
• 12.4. Operating Room
• 12.5. Pre Hospital

13. Airway Management Devices Market, by Size

• 13.1. Adult
• 13.2. Neonatal
• 13.3. Pediatric

14. Airway Management Devices Market, by Region

• 14.1. Americas
  • 14.1.1. North America
  • 14.1.2. Latin America
• 14.2. Europe, Middle East & Africa
  • 14.2.1. Europe
  • 14.2.2. Middle East
  • 14.2.3. Africa
• 14.3. Asia-Pacific

15. Airway Management Devices Market, by Group

• 15.1. ASEAN
• 15.2. GCC
• 15.3. European Union
• 15.4. BRICS
• 15.5. G7
• 15.6. NATO

16. Airway Management Devices Market, by Country

• 16.1. United States
• 16.2. Canada
• 16.3. Mexico
• 16.4. Brazil
• 16.5. United Kingdom
• 16.6. Germany
• 16.7. France
• 16.8. Russia
• 16.9. Italy
• 16.10. Spain
• 16.11. China
• 16.12. India
• 16.13. Japan
• 16.14. Australia
• 16.15. South Korea

17. Competitive Landscape

• 17.1. Market Share Analysis, 2024
• 17.2. FPNV Positioning Matrix, 2024
• 17.3. Competitive Analysis
  • 17.3.1. Medtronic plc
  • 17.3.2. Teleflex Incorporated
  • 17.3.3. Ambu A/S
  • 17.3.4. Becton, Dickinson and Company
  • 17.3.5. Dragerwerk AG & Co. KGaA
  • 17.3.6. Smiths Group plc
  • 17.3.7. Olympus Corporation
  • 17.3.8. Vyaire Medical GmbH
  • 17.3.9. Karl Storz SE & Co. KG
  • 17.3.10. Cook Incorporated